NYSE: DPLO

+0.29 +0.8% $ 36.78 Volume: 202,105 Common Stock | 20 minute delay July 22, 2016

One Patient at a Time.

Diplomat opened its doors in 1975 as a neighborhood pharmacy with one essential tenet: ‘‘Take good care of patients, and the rest falls into place.’’ Today, that tradition continues and we have focused on creating a culture that is highly focused on improving patient care and clinical adherence.

We believe that our primary focus on the patient differentiates us from our competition. We understand that the primary concerns of a patient facing a chronic and serious condition are quality of care and ease of working with the pharmacy. We believe that our detailed, well managed, high-touch patient care program that is designed to address these concerns is essential to our success. Our specialty drug dispensing and services business model creates partnerships with patients, payors, pharmaceutical manufacturers and physicians—with a focus on improving adherence and the patient experience.

Date Filing Filing Description Download
July 5, 2016 4 Statement of Changes in Beneficial Ownership
June 7, 2016 8-K Current report filing
June 2, 2016 4 Statement of Changes in Beneficial Ownership

NYSE: DPLO

+0.29 +0.8% $ 36.78 Volume: 202,105 Common Stock | 20 minute delay July 22, 2016

Investor Contact

Asher S. Dewhurst

Investor Relations,
Westwicke Partners, LLC.
diplomat@westwicke.com

Phone: 443.213.0500

Email Now